Search research articles
Contact Us
Filters
Showing results (131-140 of 216) with videos related to
Page
of 22
Sort By:
Journal for Immunotherapy of Cancer
|
August 16, 2017
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Ashish M Kamat, Joaquim Bellmunt, Matthew D Galsky, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Science Translational Medicine
|
April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Sumit K Subudhi, Luis Vence, Hao Zhao, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
European Urology
|
January 8, 2018
Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71]
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Cancer Immunology Research
|
May 28, 2015
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
Xian-De Liu, Anh Hoang, Lijun Zhou, et al.
Nature Communications
|
August 31, 2018
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
Li Wang, Abdel Saci, Peter M Szabo, et al.
Cancer Immunology Research
|
March 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome
Candice C Poon, Shelley M Herbrich, Yulong Chen, et al.
NPJ Precision Oncology
|
May 20, 2025
Multimodal spatial proteomic profiling in acute myeloid leukemia
Christopher P Ly, Ivo Veletic, Christopher D Pacheco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2021
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Li Wang, John P Sfakianos, Kristin G Beaumont, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 216) with videos related to
Sort By:
Page
of 22
Journal for Immunotherapy of Cancer
|
August 16, 2017
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Ashish M Kamat, Joaquim Bellmunt, Matthew D Galsky, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Science Translational Medicine
|
April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Sumit K Subudhi, Luis Vence, Hao Zhao, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
European Urology
|
January 8, 2018
Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71]
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Cancer Immunology Research
|
May 28, 2015
Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
Xian-De Liu, Anh Hoang, Lijun Zhou, et al.
Nature Communications
|
August 31, 2018
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
Li Wang, Abdel Saci, Peter M Szabo, et al.
Cancer Immunology Research
|
March 25, 2025
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome
Candice C Poon, Shelley M Herbrich, Yulong Chen, et al.
NPJ Precision Oncology
|
May 20, 2025
Multimodal spatial proteomic profiling in acute myeloid leukemia
Christopher P Ly, Ivo Veletic, Christopher D Pacheco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2021
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
Li Wang, John P Sfakianos, Kristin G Beaumont, et al.
Page
of 22